One of the most promising aspects of epigenetic changes is their reversibility. Unlike genetic mutations, epigenetic modifications can be potentially reversed through various therapeutic interventions. Drugs known as epigenetic therapies are being developed to target and reverse abnormal epigenetic modifications. For example, DNA methyltransferase inhibitors and histone deacetylase inhibitors are being tested in clinical trials for their efficacy in treating different types of cancer.
